• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by DocGo Inc.

    4/30/25 10:53:25 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    DocGo Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    256086109

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    256086109


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    54,316.00
    7Sole Dispositive Power

    5,379,886.00
    8Shared Dispositive Power

    89,342.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,469,228.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.36 %
    12Type of Reporting Person (See Instructions)

    IA


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    DocGo Inc
    (b)Address of issuer's principal executive offices:

    35 West 35th Street, Floor 6, New York, NY, 10001
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd., Malvern, PA 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    256086109
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    5469228
    (b)Percent of class:

    5.36  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    54316

     (iii) Sole power to dispose or to direct the disposition of:

    5379886

     (iv) Shared power to dispose or to direct the disposition of:

    89342

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:04/30/2025
    Get the next $DCGO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/23/25 4:25:30 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/15/25 5:05:47 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Director Klasko Stephen K. M.D. bought $22,350 worth of shares (15,000 units at $1.49) (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/14/25 5:42:40 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    SEC Filings

    See more
    • DocGo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - DocGo Inc. (0001822359) (Filer)

      6/18/25 4:21:01 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - DocGo Inc. (0001822359) (Filer)

      6/12/25 4:22:48 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by DocGo Inc.

      10-Q - DocGo Inc. (0001822359) (Filer)

      5/8/25 4:35:04 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DocGo Announces Upcoming Participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

      DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Company will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24 and 25, 2025. Representing the Company, CEO Lee Bienstock will deliver a presentation at 1:00 ET on Tuesday, June 24, followed by one-on-one meetings with investors on Wednesday, June 25. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. iAccess Alpha hosts virtual investor conferences featuring companies recommended by investors. These two-da

      6/18/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Announces Upcoming Participation at the Goldman Sachs 46th Annual Global Healthcare Conference

      DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at https://ir.docgo.com/. About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is

      6/2/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo Wins "Compliance Management Innovation Award" in 2025 MedTech Breakthrough Awards Program

      Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the "Compliance Management Innovation Award" in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's breakthrough Compliance Program excels at adapting to the organization's dynamic environment and consis

      5/19/25 7:35:00 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DocGo downgraded by BTIG Research

      BTIG Research downgraded DocGo from Buy to Neutral

      5/9/25 8:41:42 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • DocGo downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

      2/28/25 8:51:46 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on DocGo with a new price target

      BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

      8/18/23 7:24:03 AM ET
      $DCGO
      Medical/Nursing Services
      Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/23/25 4:25:30 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/15/25 5:05:47 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care
    • Chief Executive Officer Bienstock Lee covered exercise/tax liability with 15,565 shares, decreasing direct ownership by 0.79% to 1,955,514 units (SEC Form 4)

      4 - DocGo Inc. (0001822359) (Issuer)

      5/15/25 5:03:33 PM ET
      $DCGO
      Medical/Nursing Services
      Health Care